41例Caroli病的临床特征分析

崔延飞; 余思邈; 田淼; 桑秀秀; 王立福; 孙永强; 景婧; 王仲霞; 王丽苹; 许文涛; 王睿林

doi:10.3969/j.issn.1001-5256.2020.10.020

41例Caroli病的临床特征分析

DOI: 10.3969/j.issn.1001-5256.2020.10.020

1. 河南中医药大学
2. 解放军总医院第五医学中心中西医肝病诊疗与研究中心

基金项目:

国家自然科学基金面上项目(81673806)；保健专项科研课题(17BJZ53)；

详细信息

中图分类号: R575
计量
- 文章访问数: 870
- HTML全文浏览量: 44
- PDF下载量: 106
- 被引次数: 0
出版历程
- 收稿日期: 2020-04-22
- 出版日期: 2020-10-20

Clinical features of Caroli disease: An analysis of 41 cases

Henan University of Traditional Chinese Medicine
Liver Disease Center for Combined TCM and Western Medicine,The Fifth Medical Center of Chinese PLA General Hospital

Research funding:

摘要

摘要: 目的分析Caroli病患者的临床特征。方法收集2015年4月-2020年1月于解放军总医院第五医学中心已确诊的41例Caroli病患者的临床资料,将患者分为Ⅰ型（n=16）和Ⅱ型（n=25）,对两组患者的一般资料、实验室指标及临床特征等进行回顾性分析,满足正态分布的计量资料组间比较采用独立样本t检验,不满足正态分布的组间比较采用Mann-Whitney U检验,计数资料组间比较采用χ2检验,相关性分析采用Spearman相关分析。结果Ⅰ型患者的Alb水平高于Ⅱ型患者（t=0.976,P=0.048）,Ⅱ型患者的PT水平大于Ⅰ型患者（Z=3.115,P=0.001）;Ⅱ型患者食管胃底静脉曲张、上消化道出血和/或黑便、门静脉高压的发生率显著高于Ⅰ型患者（χ2值分别为6.077、5.468、2.403,P值分别为0.002、0.019、0.028）;Ⅱ型患者ChE水平与食管胃底静脉曲张、门静脉高压的发生率呈负相关（r值分别为-0.468、-0.436,P值分别为0.018、0.029）; Alb水平与食管胃底静脉曲张发生率呈负相关（r=-0.561...
- Caroli病 /
- 病理状态,解剖学 /
- 预后
Abstract: Objective To investigate the clinical features of patients with Caroli disease. Methods The clinical data were collected from41 patients who were diagnosed with Caroli disease in The Fifth Medical Center of Chinese PLA General Hospital from April 2015 to January2020,and the patients were divided into type I group with 16 patients and type Ⅱ group with 25 patients. A retrospective analysis was performed for general information,laboratory markers,and clinical features. The independent samples t-test was used for comparison of normally distributed continuous data between groups,and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between groups; the chi-square test was used for comparison of categorical data; a Spearman correlation analysis was also performed. Results The type Ⅰ group had a significantly higher level of albumin( Alb) than the type Ⅱ group( t = 0. 976,P = 0. 048),and the type Ⅱ group had a significantly higher prothrombin time( PT) than the type I group( Z = 3. 115,P = 0. 001). Compared with the type I group,the type Ⅱ group had significantly higher incidence rates of esophageal and gastric varices,upper gastrointestinal bleeding and/or tarry stool,and portal hypertension( χ2= 6. 077,5. 468,and 2. 403,P = 0. 002,0. 019,and 0. 028). In the patients with type Ⅱ Caroli disease,the level of cholinesterase was negatively correlated with the incidence rates of esophageal and gastric varices and portal hypertension( r =-0. 468 and-0. 436,P = 0. 018 and 0. 029); Alb level was negatively correlated with the incidence rate of esophageal and gastric varices( r =-0. 561,P = 0. 004); red blood cell count was negatively correlated with the incidence rates of esophageal and gastric varices,upper gastrointestinal bleeding and/or tarry stool,and portal hypertension( r =-0. 662,-0. 566,and-0. 436,P < 0. 001,P = 0. 003,and P = 0. 029); hemoglobin count was negatively correlated with the incidence rates of esophageal and gastric varices,upper gastrointestinal bleeding and/or tarry stool,and portal hypertension( r =-0. 605,-0. 590,and-0. 510,P = 0. 001,0. 002,and 0. 009); PT was positively correlated with the incidence rates of esophageal varices and portal hypertension( r = 0. 488 and 0. 520,P = 0. 013 and 0. 008).Conclusion Compared with the patients with type I Caroli disease,the patients with type Ⅱ Caroli disease have a higher incidence rates of esophageal and gastric varices,upper gastrointestinal bleeding and/or tarry stool,and portal hypertension,with the changes in clinical indicators such as the decrease of Alb level and the increase of PT level,and they tend to have poor prognosis.
- Caroli disease /
- pathological conditions,anatomical /
- prognosis

HTML全文

参考文献(17)

[1] BAUMGARTNER K,KBLER J,BITZER M,et al. Caroli’s syndrome[J]. Rofo,2020,192(2):119-122.

[2] MOSLIM MA,GUNASEKARAN G,VOGT D,et al. Surgical management of Caroli’s disease:Single center experience and review of the literature[J]. J Gastrointest Surg,2015,19(11):2019-2027.

[3] YONEM O,BAYRAKTAR Y. Clinical characteristics of Caroli’s syndrome[J]. World J Gastroenterol,2007,13(13):1934-1937.

[4] KERKAR N,NORTON K,SUCHY FJ. The hepatic fibrocystic diseases[J]. Clin Liver Dis,2006,10(1):55-71,v-vi.

[5] PARADA LA,HALLN M,HGERSTRAND I,et al. Clonal chromosomal abnormalities in congenital bile duct dilatation(Caroli’s disease)[J]. Gut,1999,45(5):780-782.

[6] OBUSEZ EC,UDAYASANKAR U. Autosomal recessive polycystic kidney disease with Caroli syndrome[J]. J Urol,2015,193(2):679-680.

[7] HAN X,DING XL,LI XM,et al. Gastrointestinal bleeding induced by Caroli disease:A case report[J]. J Clin Hepatol,2020,36(1):169-170.(in Chinese)韩西，丁晓玲，李雪梅，等．Caroli病引发上消化道出血1例报告[J]．临床肝胆病杂志，2020,36(1):169-170.

[8] FAHRNER R,DENNLER S,DONDORF F,et al. Liver resection and transplantation in Caroli disease and syndrome[J]. J Visc Surg,2019,156(2):91-95.

[9] WU X,WU MJ,LUO SQ,et al. Clinical characteristics of Caroli disease typeⅠandⅡ—analysis of 78 cases[J]. Gastroenterology,2016,21(7):424-428.(in Chinese)吴欣，吴孟晋，罗生强，等．Caroli病Ⅰ、Ⅱ型的临床特征—78例分析[J]．胃肠病学，2016,21(7):424-428.

[10] CNOSSEN WR,DRENTH JP. Polycystic liver disease:An overview of pathogenesis,clinical manifestations and management[J]. Orphanet J Rare Dis,2014,9:69.

[11] CHEN GY,NUEZ G. Sterile inflammation:Sensing and reacting to damage[J]. Nat Rev Immunol,2010,10(12):826-837.

[12] LI YY,TIAN SF,CAI YX,et al. Clinicopathological characteristics and literature review of Caroli disease[J]. J Wuhan Univ(Medical Edition),2020,41(1):149-152.(in Chinese)李跃莹，田素芳，蔡宇翔，等．Caroli病的临床病理特征及文献复习[J]．武汉大学学报(医学版)，2020,41(1):149-152.

[13] ZHANG Y,YU YS,TANG ZH,et al. Clinical value of combined detection of serum retinol binding protein,prealbumin and albumin in patients with hepatitis B cirrhosis[J]. J Clin Hepatol,2009,25(6):422-424.(in Chinese)张毅，余永胜，汤正好，等．乙肝肝硬化患者联合检测血清视黄醇结合蛋白、前白蛋白和白蛋白的临床价值[J]．临床肝胆病杂志，2009,25(6):422-424.

[14] DESMET VJ. Ludwig symposium on biliary disorders--part I. Pathogenesis of ductal plate abnormalities[J]. Mayo Clin Proc,1998,73(1):80-89.

[15] WANG J,ZHENG GZ. Analysis of factors related to rupture and bleeding of esophageal varices due to liver cirrhosis[J/CD].Chin J Hepatol(Electronic Edition),2019,11(1):42-46.(in Chinese)王娟，郑鸽之．肝硬化食管静脉曲张破裂出血相关因素分析[J/CD]．中国肝脏病杂志(电子版)，2019,11(1):42-46.

[16] XIONG Z,LIU YY,HUO SK,et al. Research advances in vitamin K1 in treatment of coagu-lopathy of liver failure[J]. J Clin Hepatol,2019,35(9):2099-2103.(in Chinese)熊壮，刘扬扬，霍少凯，等．维生素K1治疗肝衰竭凝血功能障碍的研究进展[J]．临床肝胆病杂志，2019,35(9):2099-2103.

[17] ZHAO YX,CAO MB. Analysis of risk factors related to cirrhosis complicated with esophageal varices bleeding[J]. J Xin xiang Med Coll,2018,35(10):869-873.(in Chinese)赵迤璇，曹名波．肝硬化并发食管静脉曲张破裂出血的相关危险因素分析[J]．新乡医学院学报，2018,35(10):869-873.

施引文献

资源附件(0)

访问统计